Effect of histological damage on long-term kidney transplant outcome
- PMID: 11258430
- DOI: 10.1097/00007890-200102270-00006
Effect of histological damage on long-term kidney transplant outcome
Abstract
Background: Chronic renal allograft failure remains a major challenge to overcome. Factors such as donor quality, delayed graft function (DGF), acute rejection, and immunosuppression are known to affect long-term outcome, but their relationship to histological damage to graft outcome is unclear.
Methods: Protocol kidney biopsies (n=112) obtained at 3 months after transplantation yielded 102 with adequate tissue. Histology was scored by the Banff schema, and compared with implantation biopsies (n=91), repeat 12-month histology (n=39), decline in serum creatinine and serial isotopic glomerular filtration rate, onset of chronic allograft nephropathy (CAN), and actuarial graft survival censored for death with a functioning graft.
Results: At a median follow-up of 9.3 years, 20 patients had graft failure and 26 died with a functioning graft. Banff chronic nephropathy was present in 24% of 3-month biopsies, and was predicted by microvascular disease in the donor, cold ischemia, DGF, and acute vascular rejection (P<0.001). Acute glomerulitis at 3 months correlated with segmental glomerulosclerosis at 12 months, subsequent recurrent glomerulonephritis, and graft failure (P<0.01). Subclinical rejection at 3 months occurred in 29% of biopsies, correlated with prior acute rejection and HLA mismatch, and led to chronic histological damage by 12 months (r=0.25-0.67, P<0.05-0.001). Subclinical rejection, arteriolar hyalinosis, and tubulitis present at 3 months had resolved by 12 months. The 10-year survival rates for Banff chronic nephropathy were 90.4% for grade 0, 81.0% grade 1, and 57.9% for grades 2 or greater (P<0.01). Early tubulointerstitial damage at 3 months profoundly influenced graft survival beyond 10 years. CAN was predicted by kidney ischemia, 3-month chronic intimal vascular thickening, tubular injury, proteinuria, and late rejection. Chronic fibrointimal thickening of the small arteries and chronic interstitial fibrosis at 3 months independently predicted graft loss and decline in renal function (P<0.05-0.001).
Conclusions: Early transplant damage occurs in the tubulointerstitial compartment from preexisting donor kidney injury and discrete events such as vascular rejection and DGF. Subsequent chronic damage and graft failure reflect accumulated previous injury and chronic interstitial fibrosis, vascular impairment, subclinical rejection, and injury from late rejection. CAN may be conceptualized as the sequelae of incremental and cumulative damage to the transplanted kidney. The duration of graft survival is dependent and predicted by the quality of the transplanted donor kidney combined with the intensity, frequency, and irreversibility of these damaging insults.
Similar articles
-
Predictors of renal transplant histology at three months.Transplantation. 1999 May 15;67(9):1222-30. doi: 10.1097/00007890-199905150-00005. Transplantation. 1999. PMID: 10342313
-
The natural history of chronic allograft nephropathy.N Engl J Med. 2003 Dec 11;349(24):2326-33. doi: 10.1056/NEJMoa020009. N Engl J Med. 2003. PMID: 14668458
-
Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.Exp Clin Transplant. 2018 Aug;16(4):391-400. doi: 10.6002/ect.2016.0323. Epub 2017 Dec 5. Exp Clin Transplant. 2018. PMID: 29206090
-
Risk factors associated with the deterioration of renal function: the role of protocol biopsies.Prilozi. 2007 Jul;28(1):291-302. Prilozi. 2007. PMID: 17932475 Review.
-
Chronic allograft nephropathy: current concepts and future directions.Transplantation. 2006 Mar 15;81(5):643-54. doi: 10.1097/01.tp.0000190423.82154.01. Transplantation. 2006. PMID: 16534463 Review.
Cited by
-
Long-term effects of average calcineurin inhibitor trough levels (over time) on renal function in a prospectively followed cohort of 150 kidney transplant recipients.Clin Transl Sci. 2023 Nov;16(11):2382-2393. doi: 10.1111/cts.13639. Epub 2023 Oct 10. Clin Transl Sci. 2023. PMID: 37817405 Free PMC article. Clinical Trial.
-
Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients.J Transl Med. 2014 Dec 10;12:331. doi: 10.1186/s12967-014-0331-x. J Transl Med. 2014. PMID: 25491391 Free PMC article. Clinical Trial.
-
Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique.J Am Soc Nephrol. 2016 Aug;27(8):2382-91. doi: 10.1681/ASN.2015050601. Epub 2015 Dec 18. J Am Soc Nephrol. 2016. PMID: 26683669 Free PMC article.
-
Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients.Pediatr Transplant. 2006 Nov;10(7):766-7. doi: 10.1111/j.1399-3046.2006.00572.x. Pediatr Transplant. 2006. PMID: 17032420 Free PMC article. No abstract available.
-
Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients.Br J Clin Pharmacol. 2016 Jul;82(1):227-37. doi: 10.1111/bcp.12946. Epub 2016 May 10. Br J Clin Pharmacol. 2016. PMID: 27334415 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials